Campo C - Search Results

1

First-line eradication rates comparing two shortened non-bismuth quadruple regimens against Helicobacter pylori: an open-label, randomized, multicentre clinical trial.

Cuadrado-Lavín A, Salcines-Caviedes JR, Diaz-Perez A, Carrascosa MF, Ochagavía M, Fernandez-Forcelledo JL, Cobo M, Fernández-Gil P, Ayestarán B, Sánchez B, Campo C, Llorca J, Lorenzo S, Illaro A. Cuadrado-Lavín A, et al. Among authors: campo c. J Antimicrob Chemother. 2015 Aug;70(8):2376-81. doi: 10.1093/jac/dkv089. Epub 2015 Apr 7. J Antimicrob Chemother. 2015. PMID: 25855760 Clinical Trial.

2

Use of the noninvasive entero-test in the detection of Helicobacter pylori in children in an endemic area in Colombia.

Arboleda RN, Schneider BG, Bravo LE, Romero-Gallo J, Peek RM Jr, Mera RM, Yepez MC, Campo C, Correa P. Arboleda RN, et al. Among authors: campo c. J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):192-6. doi: 10.1097/MPG.0b013e318293e1e1. J Pediatr Gastroenterol Nutr. 2013. PMID: 23880626 Free PMC article.

3

Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.

Bravo LE, Realpe JL, Campo C, Mera R, Correa P. Bravo LE, et al. Among authors: campo c. Am J Gastroenterol. 1999 Sep;94(9):2380-3. doi: 10.1111/j.1572-0241.1999.01361.x. Am J Gastroenterol. 1999. PMID: 10483995

4

Effect of Helicobacter pylori infection on growth velocity of school-age Andean children.

Goodman KJ, Correa P, Mera R, Yepez MC, Cerón C, Campo C, Guerrero N, Sierra MS, Bravo LE. Goodman KJ, et al. Among authors: campo c. Epidemiology. 2011 Jan;22(1):118-26. doi: 10.1097/EDE.0b013e3181fe7e31. Epidemiology. 2011. PMID: 21068668 Free PMC article.

5

Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study.

Sádaba B, Azanza JR, García-Bea A, Labeaga L, Campo C, Valiente R. Sádaba B, et al. Among authors: campo c. Eur J Drug Metab Pharmacokinet. 2020 Apr;45(2):265-272. doi: 10.1007/s13318-019-00596-2. Eur J Drug Metab Pharmacokinet. 2020. PMID: 31820304 Clinical Trial.

6

Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study.

Serra E, Campo C, Novák Z, Majorek-Olechowska B, Pulka G, García-Bea A, Labeaga L. Serra E, et al. Among authors: campo c. J Dermatolog Treat. 2020 May;31(3):270-278. doi: 10.1080/09546634.2019.1590522. Epub 2019 Apr 2. J Dermatolog Treat. 2020. PMID: 30835579 Free article. Clinical Trial.

7

Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.

Rodríguez M, Vozmediano V, García-Bea A, Novák Z, Yáñez A, Campo C, Labeaga L. Rodríguez M, et al. Among authors: campo c. Eur J Pediatr. 2020 May;179(5):801-805. doi: 10.1007/s00431-019-03559-6. Epub 2020 Jan 9. Eur J Pediatr. 2020. PMID: 31919579 Free PMC article. Clinical Trial.

8

Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.

Antonijoan R, Coimbra J, García-Gea C, Puntes M, Gich I, Campo C, Valiente R, Labeaga L. Antonijoan R, et al. Among authors: campo c. Curr Med Res Opin. 2017 Jan;33(1):129-136. doi: 10.1080/03007995.2016.1240665. Epub 2016 Oct 21. Curr Med Res Opin. 2017. PMID: 27659218 Clinical Trial.

9

Model-informed pediatric development applied to bilastine: Analysis of the clinical PK data and confirmation of the dose selected for the target population.

Vozmediano V, Lukas JC, Encinas E, Schmidt S, Sologuren A, Valiente R, Labeaga L, Campo C, Rodriguez M. Vozmediano V, et al. Among authors: campo c. Eur J Pharm Sci. 2019 Feb 1;128:180-192. doi: 10.1016/j.ejps.2018.11.016. Epub 2018 Nov 22. Eur J Pharm Sci. 2019. PMID: 30468868

10

Bilastine in allergic rhinoconjunctivitis and urticaria: a practical approach to treatment decisions based on queries received by the medical information department.

Leceta A, Sologuren A, Valiente R, Campo C, Labeaga L. Leceta A, et al. Among authors: campo c. Drugs Context. 2017 Feb 3;6:212500. doi: 10.7573/dic.212500. eCollection 2017. Drugs Context. 2017. PMID: 28210286 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters